MeSH Review:
Mammary Glands, Human
- Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Jonkers, J., Meuwissen, R., van der Gulden, H., Peterse, H., van der Valk, M., Berns, A. Nat. Genet. (2001)
- Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice. Alexander, C.M., Reichsman, F., Hinkes, M.T., Lincecum, J., Becker, K.A., Cumberledge, S., Bernfield, M. Nat. Genet. (2000)
- Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1. Roose, J., Huls, G., van Beest, M., Moerer, P., van der Horn, K., Goldschmeding, R., Logtenberg, T., Clevers, H. Science (1999)
- Expression of a calcium-mobilizing parathyroid hormone-like peptide in lactating mammary tissue. Thiede, M.A., Rodan, G.A. Science (1988)
- Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. Donehower, L.A., Godley, L.A., Aldaz, C.M., Pyle, R., Shi, Y.P., Pinkel, D., Gray, J., Bradley, A., Medina, D., Varmus, H.E. Genes Dev. (1995)
- Involvement of estrogen receptor beta in terminal differentiation of mammary gland epithelium. Förster, C., Mäkela, S., Wärri, A., Kietz, S., Becker, D., Hultenby, K., Warner, M., Gustafsson, J.A. Proc. Natl. Acad. Sci. U.S.A. (2002)
- Promotion of estrogen-induced mammary gland carcinogenesis by androgen in the male Noble rat: probable mediation by steroid receptors. Liao, D.Z., Pantazis, C.G., Hou, X., Li, S.A. Carcinogenesis (1998)
- Critical period for neonatal estrogen exposure in occurrence of mammary gland abnormalities in adult mice. Bern, H.A., Mills, K.T., Jones, L.A. Proc. Soc. Exp. Biol. Med. (1983)
- Transcriptional control of the cell cycle in mammary gland development and tumorigenesis. Coletta, R.D., Jedlicka, P., Gutierrez-Hartmann, A., Ford, H.L. Journal of mammary gland biology and neoplasia. (2004)
- Multiple roles for the major histocompatibility complex class I- related receptor FcRn. Ghetie, V., Ward, E.S. Annu. Rev. Immunol. (2000)
- Superantigens of mouse mammary tumor virus. Acha-Orbea, H., MacDonald, H.R. Annu. Rev. Immunol. (1995)
- Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology. De La Vieja, A., Dohan, O., Levy, O., Carrasco, N. Physiol. Rev. (2000)
- Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Yang, J., Mani, S.A., Donaher, J.L., Ramaswamy, S., Itzykson, R.A., Come, C., Savagner, P., Gitelman, I., Richardson, A., Weinberg, R.A. Cell (2004)
- Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis. Xu, X., Qiao, W., Linke, S.P., Cao, L., Li, W.M., Furth, P.A., Harris, C.C., Deng, C.X. Nat. Genet. (2001)
- The mammary gland iodide transporter is expressed during lactation and in breast cancer. Tazebay, U.H., Wapnir, I.L., Levy, O., Dohan, O., Zuckier, L.S., Zhao, Q.H., Deng, H.F., Amenta, P.S., Fineberg, S., Pestell, R.G., Carrasco, N. Nat. Med. (2000)
- Proliferative responses of mouse mammary glands to 17 beta-estradiol and progesterone and modification by mouse mammary tumor virus. Lee, A.E. J. Natl. Cancer Inst. (1983)
- Mammary tumorigenesis in chemical carcinogen-treated mice. IV. Induction of mammary ductal hyperplasias. Medina, D., Warner, M.R. J. Natl. Cancer Inst. (1976)
- Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor. Zajchowski, D.A., Sager, R., Webster, L. Cancer Res. (1993)
- Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas. Wu, W., Slomovitz, B.M., Celestino, J., Chung, L., Thornton, A., Lu, K.H. Cancer Res. (2003)
- The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Fata, J.E., Kong, Y.Y., Li, J., Sasaki, T., Irie-Sasaki, J., Moorehead, R.A., Elliott, R., Scully, S., Voura, E.B., Lacey, D.L., Boyle, W.J., Khokha, R., Penninger, J.M. Cell (2000)
- Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland. Johnson, M.D., Kenney, N., Stoica, A., Hilakivi-Clarke, L., Singh, B., Chepko, G., Clarke, R., Sholler, P.F., Lirio, A.A., Foss, C., Reiter, R., Trock, B., Paik, S., Martin, M.B. Nat. Med. (2003)
- Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Brisken, C., Heineman, A., Chavarria, T., Elenbaas, B., Tan, J., Dey, S.K., McMahon, J.A., McMahon, A.P., Weinberg, R.A. Genes Dev. (2000)
- Mode of action of selenium inhibition of 7,12-dimethylbenz[a]anthracene-induced mouse mammary tumorigenesis. Lane, H.W., Medina, D. J. Natl. Cancer Inst. (1985)
- Perturbation of beta1-integrin function alters the development of murine mammary gland. Faraldo, M.M., Deugnier, M.A., Lukashev, M., Thiery, J.P., Glukhova, M.A. EMBO J. (1998)
- Localization of xanthine oxidase in mammary-gland epithelium and capillary endothelium. Jarasch, E.D., Grund, C., Bruder, G., Heid, H.W., Keenan, T.W., Franke, W.W. Cell (1981)
- Thy-1 cDNA sequence suggests a novel regulatory mechanism. Moriuchi, T., Chang, H.C., Denome, R., Silver, J. Nature (1983)
- The housekeeping gene xanthine oxidoreductase is necessary for milk fat droplet enveloping and secretion: gene sharing in the lactating mammary gland. Vorbach, C., Scriven, A., Capecchi, M.R. Genes Dev. (2002)
- Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice. Nanni, P., Nicoletti, G., De Giovanni, C., Landuzzi, L., Di Carlo, E., Cavallo, F., Pupa, S.M., Rossi, I., Colombo, M.P., Ricci, C., Astolfi, A., Musiani, P., Forni, G., Lollini, P.L. J. Exp. Med. (2001)
- The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues. Marquis, S.T., Rajan, J.V., Wynshaw-Boris, A., Xu, J., Yin, G.Y., Abel, K.J., Weber, B.L., Chodosh, L.A. Nat. Genet. (1995)
- The differential actions of cortisol on the accumulation of alpha-lactalbumin and casein in midpregnant mouse mammary gland in culture. Ono, M., Oka, T. Cell (1980)
- Specificity of tissue interaction and origin of mesenchymal cells in the androgen response of the embryonic mammary gland. Dürnberger, H., Kratochwil, K. Cell (1980)
- Regression of mouse mammary gland anlagen in recombinants of Tfm and wild-type tissues: testosterone acts via the mesenchyme. Drews, U., Drews, U. Cell (1977)
- Influence of local vascularity on hormone receptors in mammary gland. Moore, B.P., Forsyth, I.A. Nature (1980)
- IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development. Cao, Y., Bonizzi, G., Seagroves, T.N., Greten, F.R., Johnson, R., Schmidt, E.V., Karin, M. Cell (2001)
- Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1. Pierce, D.F., Johnson, M.D., Matsui, Y., Robinson, S.D., Gold, L.I., Purchio, A.F., Daniel, C.W., Hogan, B.L., Moses, H.L. Genes Dev. (1993)
- A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions. Mehta, R.G., Williamson, E., Patel, M.K., Koeffler, H.P. J. Natl. Cancer Inst. (2000)
- Glycosylation-dependent cell adhesion molecule 1 (GlyCAM 1) mucin is expressed by lactating mammary gland epithelial cells and is present in milk. Dowbenko, D., Kikuta, A., Fennie, C., Gillett, N., Lasky, L.A. J. Clin. Invest. (1993)
- Long-term effects of neonatal steroid exposure on mammary gland development and tumorigenesis in mice. Mori, T., Bern, H.A., Mills, K.T., Young, P.N. J. Natl. Cancer Inst. (1976)
- Growth of mouse mammary glands after neonatal sex hormone treatment. Tomooka, Y., Bern, H.A. J. Natl. Cancer Inst. (1982)